Bitte benutzen Sie diese Kennung, um auf die Ressource zu verweisen:
https://doi.org/10.21256/zhaw-22584| Publikationstyp: | Beitrag in wissenschaftlicher Zeitschrift |
| Art der Begutachtung: | Peer review (Publikation) |
| Titel: | Beneficial and harmful effects of antidepressants versus placebo, ‘active placebo’, or no intervention for adults with major depressive disorder : a protocol for a systematic review of published and unpublished data with meta-analyses and trial sequential analyses |
| Autor/-in: | Juul, Sophie Siddiqui, Faiza Barbateskovic, Marija Jørgensen, Caroline Kamp Hengartner, Michael Pascal Kirsch, Irving Gluud, Christian Jakobsen, Janus Christian |
| et. al: | No |
| DOI: | 10.1186/s13643-021-01705-6 10.21256/zhaw-22584 |
| Erschienen in: | Systematic Reviews |
| Band(Heft): | 10 |
| Heft: | 154 |
| Erscheinungsdatum: | 2021 |
| Verlag / Hrsg. Institution: | BioMed Central |
| ISSN: | 2046-4053 |
| Sprache: | Englisch |
| Fachgebiet (DDC): | 615: Pharmakologie und Therapeutik 616.8: Neurologie und Krankheiten des Nervensystems |
| Zusammenfassung: | Background: Major depressive disorder is one of the most common, burdensome, and costly psychiatric disorders worldwide. Antidepressants are frequently used to treat major depressive disorder. It has been shown repeatedly that antidepressants seem to reduce depressive symptoms with a statistically significant effect, but the clinical importance of the effect sizes seems questionable. Both beneficial and harmful effects of antidepressants have not previously been sufficiently assessed. The main objective of this review will be to evaluate the beneficial and harmful effects of antidepressants versus placebo, 'active placebo', or no intervention for adults with major depressive disorder. Methods/design: A systematic review with meta-analysis will be reported as recommended by Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA), bias will be assessed with the Cochrane Risk of Bias tool-version 2 (ROB2), our eight-step procedure will be used to assess if the thresholds for clinical significance are crossed, Trial Sequential Analysis will be conducted to control for random errors, and the certainty of the evidence will be assessed with the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. To identify relevant trials, we will search both for published and unpublished trials in major medical databases from their inception to the present. Clinical study reports will be obtained from regulatory authorities and pharmaceutical companies. Two review authors will independently screen the results of the literature searches, extract data, and perform risk of bias assessment. We will include any published or unpublished randomised clinical trial comparing one or more antidepressants with placebo, ‘active placebo’, or no intervention for adults with major depressive disorder. The following active agents will be included: agomelatine, amineptine, amitriptyline, bupropion, butriptyline, cianopramine, citalopram, clomipramine, dapoxetine, demexiptiline, desipramine, desvenlafaxine, dibenzepin, dosulepin, dothiepin, doxepin, duloxetine, escitalopram, fluoxetine, fluvoxamine, imipramine, iprindole, levomilnacipran, lofepramine, maprotiline, melitracen, metapramine, milnacipran, mirtazapine, nefazodone, nortriptyline, noxiptiline, opipramol, paroxetine, protriptyline, quinupramine, reboxetine, sertraline, trazodone, tianeptine, trimipramine, venlafaxine, vilazodone, and vortioxetine. Primary outcomes will be depressive symptoms, serious adverse events, and quality of life. Secondary outcomes will be suicide or suicide attempt, suicidal ideation, and non-serious adverse events. Discussion: As antidepressants are commonly used to treat major depressive disorder in adults, a systematic review evaluating their beneficial and harmful effects is urgently needed. This review will inform best practice in treatment and clinical research of this highly prevalent and burdensome disorder. |
| URI: | https://digitalcollection.zhaw.ch/handle/11475/22584 |
| Volltext Version: | Publizierte Version |
| Lizenz (gemäss Verlagsvertrag): | CC BY 4.0: Namensnennung 4.0 International |
| Departement: | Angewandte Psychologie |
| Organisationseinheit: | Psychologisches Institut (PI) |
| Enthalten in den Sammlungen: | Publikationen Angewandte Psychologie |
Dateien zu dieser Ressource:
| Datei | Beschreibung | Größe | Format | |
|---|---|---|---|---|
| 2021_Juul-etal_Effects-of-antidepressants-vs-placebo.pdf | 674.34 kB | Adobe PDF |  Öffnen/Anzeigen |
Zur Langanzeige
Juul, S., Siddiqui, F., Barbateskovic, M., Jørgensen, C. K., Hengartner, M. P., Kirsch, I., Gluud, C., & Jakobsen, J. C. (2021). Beneficial and harmful effects of antidepressants versus placebo, ‘active placebo’, or no intervention for adults with major depressive disorder : a protocol for a systematic review of published and unpublished data with meta-analyses and trial sequential analyses. Systematic Reviews, 10(154). https://doi.org/10.1186/s13643-021-01705-6
Juul, S. et al. (2021) ‘Beneficial and harmful effects of antidepressants versus placebo, ‘active placebo’, or no intervention for adults with major depressive disorder : a protocol for a systematic review of published and unpublished data with meta-analyses and trial sequential analyses’, Systematic Reviews, 10(154). Available at: https://doi.org/10.1186/s13643-021-01705-6.
S. Juul et al., “Beneficial and harmful effects of antidepressants versus placebo, ‘active placebo’, or no intervention for adults with major depressive disorder : a protocol for a systematic review of published and unpublished data with meta-analyses and trial sequential analyses,” Systematic Reviews, vol. 10, no. 154, 2021, doi: 10.1186/s13643-021-01705-6.
JUUL, Sophie, Faiza SIDDIQUI, Marija BARBATESKOVIC, Caroline Kamp JØRGENSEN, Michael Pascal HENGARTNER, Irving KIRSCH, Christian GLUUD und Janus Christian JAKOBSEN, 2021. Beneficial and harmful effects of antidepressants versus placebo, ‘active placebo’, or no intervention for adults with major depressive disorder : a protocol for a systematic review of published and unpublished data with meta-analyses and trial sequential analyses. Systematic Reviews. 2021. Bd. 10, Nr. 154. DOI 10.1186/s13643-021-01705-6
Juul, Sophie, Faiza Siddiqui, Marija Barbateskovic, Caroline Kamp Jørgensen, Michael Pascal Hengartner, Irving Kirsch, Christian Gluud, and Janus Christian Jakobsen. 2021. “Beneficial and Harmful Effects of Antidepressants versus Placebo, ‘Active Placebo’, or No Intervention for Adults with Major Depressive Disorder : A Protocol for a Systematic Review of Published and Unpublished Data with Meta-Analyses and Trial Sequential Analyses.” Systematic Reviews 10 (154). https://doi.org/10.1186/s13643-021-01705-6.
Juul, Sophie, et al. “Beneficial and Harmful Effects of Antidepressants versus Placebo, ‘Active Placebo’, or No Intervention for Adults with Major Depressive Disorder : A Protocol for a Systematic Review of Published and Unpublished Data with Meta-Analyses and Trial Sequential Analyses.” Systematic Reviews, vol. 10, no. 154, 2021, https://doi.org/10.1186/s13643-021-01705-6.
Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt, soweit nicht anderweitig angezeigt.